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Abstract
Nicotinic acetylcholine receptors (nAChRs) are ligand-gated ion channels that mediate synaptic transmission in the muscle
and autonomic ganglia and regulate transmitter release in the brain. The nAChRs composed of a7 subunits are also
expressed in non-excitable cells to regulate cell survival and proliferation. Up to now, functional a7 nAChRs were found
exclusively on the cell plasma membrane. Here we show that they are expressed in mitochondria and regulate early pro-
apoptotic events like cytochrome c release. The binding of a7-specific antibody with mouse liver mitochondria was revealed
by electron microscopy. Outer membranes of mitochondria from the wild-type and b22/2 but not a72/2 mice bound a7
nAChR-specific antibody and toxins: FITC-labeled a-cobratoxin or Alexa 555-labeled a-bungarotoxin. a7 nAChR agonists
(1 mM acetylcholine, 10 mM choline or 30 nM PNU-282987) impaired intramitochondrial Ca
2+ accumulation and significantly
decreased cytochrome c release stimulated with either 90 mMC a C l 2 or 0.5 mM H2O2. a7-specific antagonist
methyllicaconitine (50 nM) did not affect Ca
2+ accumulation in mitochondria but attenuated the effects of agonists on
cytochrome c release. Inhibitor of voltage-dependent anion channel (VDAC) 4,49-diisothio-cyano-2,29-stilbene disulfonic
acid (0.5 mM) decreased cytochrome c release stimulated with apoptogens similarly to a7 nAChR agonists, and VDAC was
co-captured with the a7 nAChR from mitochondria outer membrane preparation in both direct and reverse sandwich ELISA.
It is concluded that a7 nAChRs are expressed in mitochondria outer membrane to regulate the VDAC-mediated Ca
2+
transport and mitochondrial permeability transition.
Citation: Gergalova G, Lykhmus O, Kalashnyk O, Koval L, Chernyshov V, et al. (2012) Mitochondria Express a7 Nicotinic Acetylcholine Receptors to Regulate Ca
2+
Accumulation and Cytochrome c Release: Study on Isolated Mitochondria. PLoS ONE 7(2): e31361. doi:10.1371/journal.pone.0031361
Editor: Joseph Najbauer, City of Hope National Medical Center and Beckman Research Institute, United States of America
Received August 2, 2011; Accepted January 6, 2012; Published February 16, 2012
Copyright:  2012 Gergalova et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the short-term fellowship of European Molecular Biology Organization, the Investigator Initiated Research Grant of
Alzheimer Association and the grant P5 ‘‘Fundamental Sciences to Medicine’’ of Russian Academy of Sciences. The funders had no role in study design, data
collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: skok@biochem.kiev.ua
Introduction
Nicotinic acetylcholine receptors (nAChRs) are pentameric
ligand-gated ion channels that were initially explored in muscle
and autonomic ganglia and shown to mediate fast synaptic
transmission [1]. In the brain, they regulate glutamate-, GABA-
and dopamine-mediated transmission and are involved in the
establishment of nicotine dependence [2]. Studies of the last
decade documented the presence of nAChRs and nAChR-like
receptors in many non-excitable cells of mammals, as well as in
invertebrates, plants and even bacteria, where their functions are
related to the general vital properties of living cells like
proliferation, survival, adhesion and motility [3–5]. It is becoming
increasingly clear that nAChRs have appeared in evolution long
before the development of the nervous system and that they are
multifunctional receptors employing different kinds of signaling in
the cells of various origin.
Structurally, the nAChRs are composed of combinations of ten
alpha (a1t oa10) and four beta (b1t ob4) subunits, muscle-type
receptors contain also c, d or e subunits. They can be assembled as
heteropentamers (eg. (a1)2b1cd
¨
(a3)2(b4)3,( a3)2a5(b4)2,( a4)2(b2)3,
etc.) or as homopentamers (eg. (a7)5) and, correspondingly, differ
in their cation selectivity, kinetics of the ion channel opening and
desensitization [1].
The homopentameric nAChRs composed of a7s u b u n i t s( a7
nAChRs) are of special interest, because they belong to the most
ancient branch of this receptor’s family and were shown to be
expressed in both neurons and non-excitable cells to mediate pro-
proliferative, survival and anti-inflammatory signaling [6–9].
Previously we found that the absence of these receptors in a72/2
mice resulted in poorer survival of B lymphocyte precursors within
the bone marrow [7]. Activation of nAChRs stimulated the growth
of cancer cells and suppressed apoptosis [10], and the nAChR
agonist nicotine could abolish the chemotherapy-induced apoptosis
[11]. However, up to now, the pro-survival signaling was attributed
exclusively to a7 nAChRs exposed on the cell plasma membrane.
We posed a question: whether functional a7 nAChRs can be found
inintracellularorganelles,inparticularly,inmitochondria,whichare
involved in inducing intracellular apoptotic pathway? Here we show
thata7 nAChRs areexpressed inthe outer mitochondriamembrane
to regulate Ca
2+ accumulation and cytochrome c release stimulated
with apoptogens like high Ca
2+ dose or H2O2.
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The presence of a7 nAChRs in mitochondria
Mitochondria isolated from the liver of C57Bl/6 mice were
treated with the antibody against the whole extracellular domain
(1–208) of a7 nAChR subunit, followed by the 10 nm colloidal
gold conjugated secondary antibody, and examined by electron
microscopy. As shown in Fig. 1, the binding of a7(1–208)-specific
antibody was detected on mitochondria bodies. However, positive
staining was quite rare, probably, due to the mode of sample
processing (cutting) for electron microscopy.
As the next step, we studied the presence of nAChRs in
detergent lysates of mitochondria isolated from the liver of either
wild-type or a72/2 mice. For this purpose, two types of sandwich
assays were developed (Fig. 2, A, D). The nAChR contained
within the mitochondria preparation was captured with the
antibody against a ´7(1–208) and was further revealed with either
fluorescein isothiocyanate-labeled a-cobratoxin (CTX-FITC) or
a7(179–190)-specific antibody. CTX is a long-chain a-neurotoxin
from Naja kaouthia cobra venom; a specific ligand for the muscle-
type, a ´7 and a ´9(a ´10) nAChRs of mammals [12]. Antibody against
the extracellular epitope (179–190) of a7 nAChR subunit was
generated by us previously [13] and was proven to be a7-specific
in numerous experimental systems and assays including ELISA,
Western blot and flow cytometry [7,14]. As shown in Fig. 2, B and
E, the binding of both toxin and antibody was observed with the
mitochondria of the wild-type but not a72/2 mice in two
independent assays. When the wild-type mitochondria were
fractionated into the outer (OM) and inner (IM) membranes, the
binding of both CTX-FITC and a ´7(179–190)-specific antibody
was found with the OM, but not IM preparation (that explained
the rare positive staining of cut mitochondria in electron
microscopy, Fig. 1). We further compared the OM preparations
of the wild-type, a72/2 and b22/2 mice in the antibody- and
toxin-based sandwich assays; in this case we used Alexa Fluor 555-
labeled a-bungarotoxin previously shown to bind specifically a7
nAhCRs in both a7-transfected model cells and in dorsal-root
ganglia naturally expressing this nAChR subtype [15]. As shown
in Fig. 2, C and F, positive signal was found in the preparations of
the wild-type and b22/2, but not a72/2 mitochondria. This
data clearly indicated that a7 nAChR was present in the
mitochondria outer membrane.
Regulation of Ca
2+ accumulation in mitochondria by a7
nAChR ligands
To reveal possible functions of a7 nAChRs in mitochondria,
we took into account that this nAChR subtype is highly
permeable to Ca
2+ [1], whereas mitochondria are well-known
intracellular Ca
2+ depots. To find out whether mitochondriala7
nAChRs are involved in Ca
2+ transport we studied intramito-
chondrial Ca
2+ accumulation in the presence or absence of a7-
specific ligands. To exclude any contamination with the whole
cells or plasma membranes, the isolated mitochondria were
allocated by flow cytometry according to their size and
granularity (Fig. 3, A). 95% of particles within the gated
population incorporated mitochondria-specific fluorescent dye
acridine orange 10-nonyl bromide [16] indicating that it
contained pure mitochondria (Fig. 3, B). Experiments were
performed in live mitochondria maintaining their membrane
potential monitored with the potential-sensitive fluorescent dye
tetramethyl rhodamine methyl esther [17]. Addition of 90 mM
CaCl2 to the mitochondria loaded with Ca
2+-sensitive fluorescent
dye Fluo 3-AM evoked the fluorescent signal within the first two
minutes; the signal was maintained during at least 10 min more
and was completely abolished by the addition of 1 mM EGTA
(Fig. 3, C) or 0.1 mM carbonyl cyanide-3-chlorophenylhydrazone
(CCCP, data not shown). When CaCl2 application was preceded
with that of a7 nAChR agonists choline, acetylcholine or PNU-
282987, but not a specific competitive antagonist methyllicaco-
nitine (MLA), Ca
2+ accumulation was inhibited by about 20%
(Fig. 3, D). Similar effect was exerted by the VDAC inhibitor
4,49-diisothiocyano-2,29-stilbene disulfonic acid (DIDS). VDAC is
also located in mitochondria outer membrane and facilitates Ca
2+
entry from the cytosol into the intermembrane mitochondria
space [18]. Similar effects of DIDS and a7 nAChR agonists on
Ca
2+ accumulation in mitochondria pushed us to search a further
physical and functional connection between VDAC and a7
nAChR.
Connection of a7 nAChR to VDAC in the outer
mitochondria membrane
To elucidate if there is an interaction between a7 nAChR and
VDAC in the outer mitochondria membrane we developed
another set of sandwich immunoenzyme assays presented in Fig. 4
A, C. These assays are analogues of immunoprecipitation where
the complex of two interacting proteins is captured from the
mixture with the antibody against one component and is revealed
in Western blot with the antibody against another component.
The advantage of sandwich assay is that both steps are performed
in the same media (immunoplate) and that the second antibody
binding is evaluated photometrically as in conventional ELISA.
Previously, we used such an approach to reveal the interaction of
a7 nAChR with CD40 and of a4b2 nAChRs with IgM in B
lymphocytes [19]. In the first assay, the a7 nAChR was captured
from the OM preparation with anti-a7(1–208) and was revealed
with either anti-a7(179–190) or anti-VDAC (Fig. 4, A). As shown
in Fig. 4, B, the OM preparation captured with anti-a7(1–208)
was revealed with both anti-VDAC and anti-a7(179–190). In the
‘‘reverse’’ assay (Fig. 4, C), the complex was captured with either
anti-VDAC or the antibody against mitochondria outer mem-
brane translocase (anti-TOM22) and was revealed with anti-
a7(1–208). In this case, the nAChR-specific antibody recognized
the complex captured with anti-VDAC and not with anti-
TOM22 (Fig. 4, D). These data clearly demonstrated that a7
nAChR interacts with the VDAC in the outer mitochondria
membrane.
Figure 1. Electron microscopy images of mouse liver mito-
chondria. Isolated mitochondria were stained with rabbit a7(1–208)-
specific antibody followed by 10 nm colloidal gold-conjugated anti-
rabbit IgG. A – secondary antibody only (control), B – a7(1–208)-specific
antibody plus secondary antibody; arrows (1) indicate the sites of
positive staining.
doi:10.1371/journal.pone.0031361.g001
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by a7 nAChR ligands
VDAC is a key element in mitochondria permeability transition
pore (MPTP) formation accompanied with cytochrome c (cyt c)
release [20] which is the initial step of mitochondria-driven
apoptosis. To test if mitochondrial a7 nAChRs are involved in
apoptosis-related processes, we studied the effects of a ´7 nAChR
ligands on the cyt c release from purified mitochondria stimulated
with either high dose of CaCl2 or H2O2. Preliminary data
demonstrated that cytochrome c release stimulated with 0.5 mM
H2O2 was inhibited with a7 nAChR agonists and DIDS [21].
Here we show that 90 mM CaCl2 stimulated extensive cyt c release
from live mitochondria similarly to 0.5 mM H2O2; both were
significantly inhibited with 0.5 mM DIDS or a ´7 nAChR agonists
(choline, acetylcholine or PNU-282987, Fig. 5). MLA did not
affect cyt c release itself but prevented inhibitory effects of all
agonists. This data clearly indicated that a ´7 nAChRs were
involved in regulating MPTP formation, and their activation with
agonists produced an effect similar to inhibition of VDAC by
DIDS.
Discussion
The presence of nicotinic receptors in mitochondria has initially
been discussed in connection with the neuroprotective role of
nicotine. Then it was shown that nicotine affected mitochondria
respiratory chain independently on nAChRs [22]. However, in
other studies, the decrease of mitochondria membrane potential
caused by ethanol was prevented with specific a7 nAChR agonist
2,4-dimethoxibenziliden anabasein and this effect was blocked
with MLA [23]. In the latter work, a7 nAChR agonists also
attenuated cytochrome c release stimulated by ethanol in rat
hippocampal neuronal cultures that is in good agreement with our
data. In our earlier published experiments, 1 mM nicotine
prevented Ca
2+ accumulation in isolated mitochondria similarly
to 1 mM choline, and mitochondria from mice injected with a7(1–
208)-specific antibody possessed lower membrane potential than
those from mice injected with non-specific IgG, suggesting the
involvement of a7 nAChRs [24]. The binding of a7-specific
antibody with mitochondria of rat hippocampus was demonstrated
by electron microscopy; however, this was not confirmed by
Western blot analysis [25] and, therefore, did not allow the authors
to state the expression of a7 nAChRs in mitochondria.
Our data clearly demonstrate that nAChRs of a7 subtype are
present in the outer membranes of mitochondria isolated from the
mouse liver. This was shown by electron microscopy with a7(1–
208)-specific antibody and by sandwich ELISA with a7(179–190)-
specific antibody. Since the specificity of many antibodies against
nAChRs was put in doubt [26–27], we confirmed our results by
independent binding of either a-cobratoxin or a-bungarotoxin
fluorescent derivatives and used mitochondria from the wild-type,
a72/2 or b22/2 mice to prove the specificity of binding (Fig. 2
B, C). Mouse liver is a recognized source for mitochondria
isolation [28]; it is yet to be established if mitochondria from other
Figure 2. Identification of a7 nAChRs in isolated mitochondria by sandwich ELISA. A and D – schemes of assays used; CTX-FITC – FITC-
labeled a-cobratoxin, Bgt-Alexa – Alexa Fluor 555-labeled a-bungarotoxin, PO – horseradish peroxidase. B and E – the results of the CTX-FITC-
developed (B, n=6) or antibody-developed (E, n=4) sandwich assays with the lysates of non-fractionated mitochondria from the wild-type (WT) or
a72/2 mice and the outer (OM) and inner (IM) membranes of the wild-type mitochondria. *** – P,0.0005 compared to the data of the wild-type
mitochondria and their outer membranes. C and F – the results of Bgt-Alexa-developed (C, n=8) or antibody-developed (F, n=5) sandwich assays
with the outer membranes of mitochondria from the wild-type, a72/2 or b22/2 mice; non-specific binding detected in the presence of 200-fold
molar excess of non-labeled a-cobratoxin (C) is subtracted. *** – P,0.0005 compared to the data of the outer membranes of the wild-type
mitochondria.
doi:10.1371/journal.pone.0031361.g002
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and/or subtype.
To reveal the functions of a7 nAChRs in mitochondria, we took
into account that nAChRs expressed in non-excitable cells trigger
intracellular signaling and affect the activity of adjacent receptors
by either ion-dependent or independent mechanism [29–31].
Previously we found that a7 nAChR expressed in mouse B
lymphocytes was coupled with CD40 and regulated CD40-
mediated B lymphocyte activation [19]. Similar approach applied
to mitochondria indicates that mitochondrial a7 nAChR is
coupled to VDAC that may underlie similar effects of a7 agonists
and DIDS on Ca
2+ accumulation and cyt c release (Fig. 3, D
and 5).
VDAC, positioned on the interface between mitochondria and
the cytosol, is responsible for the fluxes of various metabolites
across mitochondria outer membrane [32–33]. It is suggested to
increase the local Ca
2+ concentration in the intermembrane
mitochondria space thus facilitating the Ca
2+uniporter activity
[34]. It has been also recognized as a key protein in MPTP
formation and induction of mitochondria-mediated apoptosis [35].
VDAC is easily converted from anion-selective to cation-
permeable state by environmental conditions [36] and is
oligomerized to be involved in MPTP [18]. Similar effects of a7
nAChR agonists and of DIDS, which prevents VDAC’s
oligomerization [18], allow suggesting that mitochondrial a7
nAChR signaling affects the neighboring VDAC thus preventing
its involvement in MPTP. Interestingly, the doses of choline
(10 mM) and acetylcholine (1 mM) affecting both Ca
2+ accumula-
tion and cyt c release were much lower than those reported to open
the a7 nAChR ion channel (EC50 1.6 mM for choline and 79–
316 mM for acetylcholine); that of synthetic agonist PNU-282987
(30 nM) was closer to but still less than its reported functional
potency (128 nM) [37]. Since the effects of all tested agonists on
cyt c release were inhibited with the competitive inhibitor MLA, it
may be suggested that mitochondrial a7 nAChRs are much more
sensitive to natural agonists than those expressed in the plasma
membrane, possibly, due to specific lipid surrounding of
mitochondria outer membrane [38]. The lipids were shown to
influence the ability of the nicotinic acetylcholine receptor to
gating in response to neurotransmitter binding [39]. In addition,
the exact subunit composition of a7-containing mitochondrial
nAChRs is still to be elucidated, since heteromeric a7b2 nAChRs
were shown to possess different pharmacological sensitivity
compared to a7 homopentamers [40].
Recognizing the a7 nAChR presence in mitochondria poses a
question about its natural ligand(s) and physiological significance.
Choline is actively transported into the cell from extracellular
space and is present in the cytosol at 30 to 50 mM [41]. According
to our data, it is sufficient to activate mitochondrial a7 nAChRs
and to keep mitochondria ‘‘resistant’’ to apoptogenic agents.
However, the half-life time of intracellular choline is very short
[42], therefore, the mitochondria protection depends on the
Figure 3. The effects of a7-specific ligands and DIDS on Ca
2+ accumulation in mitochondria studied by flow cytometry. A – purified
liver mitochondria gated by size (Forward scatter) and granularity (Side scatter) in flow cytometry. B – binding of 0.1 mM acridine orange 10-nonyl
bromide (NAO) to the gated mitochondria population; Control – the non-stained mitochondria. C –C a
2+ accumulation in mitochondria loaded with
Fluo 3-AM. D –C a
2+ accumulated in mitochondria during 2 min after 1 min pretreatment with DIDS, acetylcholine, choline, PNU-282987 or MLA; data
are shown as normalized mean fluorescence values of 5 independent experiments for each ligand; * – P,0.05 compared to the fluorescence in the
absence of a7 nAChR agonists or DIDS.
doi:10.1371/journal.pone.0031361.g003
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strates the increased susceptibility of mitochondria to calcium-
induced permeability transition upon choline deficiency [43] that
supports our idea. In contrast, intracellular release of choline upon
ischemia [42] obviously has the protective anti-apoptotic effect. In
addition, according to proteomic studies, mitochondria contain
choline acetyltransferase [44] and, therefore, are able to locally
synthesize acetylcholine.
In summary, our results demonstrate that a ´7 nAChRs are
expressed on mitochondria outer membrane and regulate Ca
2+
accumulation and cyt c release, the initial step of apoptosis
induction. This means that, in addition to established anti-
apoptotic signaling pathways mediated by plasma membrane a7
nAChRs [8–9], there is an endogenous, previously unrecognized
cholinergic mechanism to control mitochondria functions and
their apoptotic susceptibility. Probably, it belongs to the most
Figure 4. Connection of a7 nAChR and VDAC studied by sandwich assays. The schemes (A, C) and results of direct (B, n=3) and reverse (D,
n=3) sandwich assays demonstrating the connection of a7 nAChR and VDAC in the outer membranes (OM) of the wild-type (WT) mitochondria. Anti-
TOM22 – antibody against mitochondrial outer membrane translocase.
doi:10.1371/journal.pone.0031361.g004
Figure 5. Cytochrome c release into mitochondria supernatants. Cyt c released from mitochondria in 2 min after addition of either 0.5 mM
H2O2 or 90 mM CaCl2 in the presence or absence of DIDS or a7 nAChR ligands. Each column corresponds to M6SE of three independent
measurements. Mit – mitochondria without apoptogens; Contr – mitochondria treated with H2O2 or CaCl2 only.
doi:10.1371/journal.pone.0031361.g005
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hypothetic prokaryotic ancestor [45]. This finding offers a novel
view on the mitochondria protection in apoptosis and opens the
way for its pharmacological regulation.
Materials and Methods
Ethics Statement
We used age-matched male wild-type and mutant (lacking
either a7o rb2 nicotinic receptor subunit [46–47]) mice with
common C57BL/6J background. The mice were kept in the
animal facilities of Pasteur Institute, Paris and Palladin Institute of
Biochemistry, Kyiv. They were housed in a quiet, temperature-
controlled room (22–23uC) and were provided with water and dry
food pellets ad libitum. Before removing the liver mice were
sacrificed by cervical dislocation. All procedures conformed to the
guidelines of the Centre National de la Recherche Scientifique or
IACUC of Palladin Institute. Before starting the experiments, the
protocols were approved by the Animal Care and Use Committee
of Palladin Institute of Biochemistry (Protocol 1/7-421).
Reagents
All reagents were of chemical grade and were purchased from
Sigma-Aldrich unless specially indicated. Alexa Fluor 555 a-
bungarotoxin was purchased from Invitrogen (USA). CTX-FITC
and antibodies against a7(1–208) or a7(179–190) were obtained by
us previously [13,48–49].
Mitochondria purification and fractionation
Mitochondria isolation from the mouse liver and fractionation
into inner and outer membranes was performed by differential
ultracentrifugation according to standard procedure described
[50]. The separation medium contained 10 mM HEPES, 1 mM
EGTA and 250 mM sucrose, pH 7.4, 4uC. For the membrane
preparation, the isolated mitochondria were resuspended in 10 ml
10 mM KH2PO4, left on ice for 5 min and spun at 8000 g for
10 min. The pellet was resuspended in 10 ml 125 mM KCl,
10 mM Tris-MOPS (pH 7.4, 4uC) and centrifuged again. The
supernatant was withdrawn, while the pellet was resuspended in
the mixture of 10 mM KH2PO4 (10 ml) and 1.8 M sucrose,
2 mM ATP, 2 mM MgSO4 (3.5 ml). The sample was sonicated at
4 W for 20 min, laid on the top of 15 ml 1.18 M sucrose and spun
for 2 h at 90 000 g. The inner membranes were collected as the
brown pellet in the tube bottom, while the outer membranes were
found precipitated in the interphase. To prepare detergent lysates,
the mitochondria suspension or membrane fractions were freezed
at 270uC, thawed and treated with the lysing buffer (0.01 M Tris
–HCl, pH 8.0; 0.14 M NaCl; 0.025% NaN3; 1% Tween 20) and
protease inhibitors cocktail for 2 h on ice upon intensive stirring.
The resulting lysate was cleared by centrifugation (20 min at
20 000 g) and dialysed against PBS containing 0.025% NaN3 and
protease inhibitors. The protein concentration was established by
Bradford assay.
Electron microscopy
The purified mitochondria were treated in suspension with
a7(1–208)-specific rabbit antibody (0.05 mg/ml) for 30 min at
RT, washed by centrifugation and subsequently incubated with
10 nm colloidal gold-labeled goat anti-rabbit immunoglobulins for
additional 30 min. Control preparation was treated with the
second antibody only. The washed mitochondria were pelleted
and fixed with 2.5% glutaraldehyde in 0.1 M sodium cacodylate
buffer pH 7.4 during 3 h at RT. The samples were additionally
fixed with 1% OsO4 in 0.05 M cacodylate buffer during 2 h and
were dehydrated in 30%, 50%, 70%, 90% and 100% acetone
subsequently. The obtained preparations were polymerized in
epoxy resin Apon-Araldyt (AGAR, UK). Ultrathin lesions (70–
100 nm) were prepared with Ultratome LKB-V (LKB, Sweden)
and were stained with 1% uranyl acetate (60 min) and the lead dye
(2 min). The preparations were analyzed under electron micro-
scope H-600 (Hitachi, Japan) with 20,000 amplification.
Flow cytometry studies
The purified mitochondria (200 mg of protein per ml in the
standard sample) were resuspended in the incubation medium
containing 10 mM HEPES, 125 mM KCl, 25 mM NaCl, pH 7.4.
For Ca
2+-related studies the incubation medium was supplement-
ed with 5 mM sodium succinate and 0.1 mM Pi(K), pH 7.4. The
purity of gated mitochondria in flow cytometry was assessed using
0.1 mM acridine orange 10-nonyl bromide (NAO) added imme-
diately before flow cytometry examination. For Ca
2+ uptake
studies, mitochondria were pre-incubated with 1 mM Fluo 3-AM
for 30 min in the dark. CaCl2, DIDS and a7 nAChR ligands were
added as described in the Fig. 3 and its legend. The studies were
performed with the COULTER EPICS-XL
TM fluorescent flow
cytometer (Beckman Coulter, USA) at room temperature.
Sandwich assays
The 96-well plates (Nunc MaxiSorp, Denmark) were coated
with rabbit a7(1–208)-specific antibody and were subsequently
blocked with 1% BSA/PBS. The detergent lysates of mitochondria
or their membranes were applied into the coated wells, 600 mg/ml
(for the whole lysate) or 100 mg/ml (for membranes). After 2 h of
incubation at 37uC the plates were washed with water. In ELISA
version, the bound antigen was revealed with biotinylated rabbit
a7(179–190)-specific antibody or VDAC-specific antibody (Santa
Cruz Biotechnology, USA) applied for additional 2 h and followed
by Extravidin-peroxidase conjugate and o-phenylenediamine-
containing substrate solution. The absorbance at 490 nm was
read by the StatFax-2100 Microplate reader (Awareness Tech-
nology, USA). In the combined antibody-toxin version, the bound
antigen was detected with either CTX-FITC (10–20 mg/ml) or
Alexa Fluor 555-labeled a-bungarotoxin in 50 nM final concen-
tration applied for 1 h (CTX) or overnight (a-bungarotoxin) at RT
and washed out with PBS. The fluorescence of dry plates was then
read with FLx800 Multi-detection microplate reader (BioTek,
USA) or fluorimeter FFM-01 (Kortek, Russia) using excitation/
emission wavelength of 485/530 nm or 546/607, respectively.
Cyt c release studies
The purified mitochondria (120 mg of protein per ml) were
incubated with either 90 mM CaCl2 or 0.5 mM H2O2 in the
presence or absence of DIDS or nAChR ligands for 2 min at room
temperature and were immediately pelleted by centrifugation
(10 min., 7000 g) at 4uC. The supernatants were collected and
tested by sandwich assay. The plates were coated with ammonium
sulfate-precipitated fraction of bovine cyt c-specific rabbit
antiserum and blocked with 1% BSA. Mitochondria supernatants
were applied at optimal dilutions established in preliminary
experiments. Calibration curve was built using bovine cyt c. The
bound cyt c was revealed with biotinylated immunoglobulins from
cyt c-specific rabbit serum followed by Extravidin-peroxidase
conjugate and o-phenylendiamin-containing substrate solution.
This assay became possible because of multiple epitopes
recognized on cyt c by polyclonal antibodies and due to evolutional
conservatism of cyt c molecule, so that antibodies raised against
bovine cyt c could recognize its mouse analogue.
Nicotinic Acetylcholine Receptors in Mitochondria
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Each experiment was reproduced independently minimum
three times with 3 to 6 repeats for each point. Statistical analysis
was performed according to Student’s test using OriginPro 8.6
software. The data are presented as mean and SEM. The
difference was considered significant at P,0.05 (*).
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